BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9467955)

  • 1. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    O'Hagan RC; Hassell JA
    Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
    Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
    Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
    Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
    Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
    York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
    Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
    J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
    Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
    J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
    Castillo AI; Tolon RM; Aranda A
    Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
    Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
    J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
    Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
    Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA.
    Janknecht R; Monté D; Baert JL; de Launoit Y
    Oncogene; 1996 Oct; 13(8):1745-54. PubMed ID: 8895521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.